Antheia Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 52

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

Antheia General Information

Description

Operator of a biotechnology company intended to develop plant-inspired medicines. The company's cost-competitive, plant-based medicines are made using synthetic biology, informatics, and fermentation technology to harness beneficial molecules from plants to create active pharmaceutical ingredients, enabling healthcare organizations to provide patients with natural and healthier medication.

Contact Information

Website
www.antheia.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Corporate Office
  • 1430 O'Brien Drive
  • Suite A
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Antheia Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antheia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 21-Dec-2023 00000 Completed Generating Revenue
12. Later Stage VC 31-Aug-2022 0000 00000 Completed Generating Revenue
11. Later Stage VC (Series B) 30-Jun-2021 0000 000.00 00000 Completed Product Development
10. Debt - PPP 13-Apr-2020 00000 000.00 Completed Product Development
9. Debt - General 31-Dec-2019 00.000 000.00 Completed Product Development
8. Debt - General 01-Dec-2018 00.000 000.00 Completed Product Development
7. Later Stage VC (Series B) 04-Sep-2018 00.00 000.00 00000 Completed Product Development
6. Grant 01-Jan-2018 00000 00.00 Completed Startup
5. Early Stage VC (Series A) 26-May-2017 $6.22M $8.2M 000.00 Completed Startup
4. Grant 01-Jan-2017 $900K $1.97M Completed Startup
To view Antheia’s complete valuation and funding history, request access »

Antheia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-3 0,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series B-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.00
Series B-1 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A 6,880,436 $0.000100 $0.71 $8.89 $8.89 1x $8.6 26.27%
Seed 2,237,536 $0.000100 $0.09 $1.12 $1.12 1x $1.12 8.27%
To view Antheia’s complete cap table history, request access »

Antheia Patents

Antheia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240000715-A1 Oxygen capsule as well as preparation method and application thereof Pending 19-Oct-2021 0000000000
EP-4247937-A1 Methods of improving production of morphinan alkaloids and derivatives Pending 19-Nov-2020 000000000
US-20240102061-A1 Methods of improving production of morphinan alkaloids and derivatives Pending 19-Nov-2020 000000000
EP-3947633-A1 Methods of improving production of morphinan alkaloids and derivatives Pending 26-Mar-2019 0000000000
EP-3947633-A4 Methods of improving production of morphinan alkaloids and derivatives Pending 26-Mar-2019 C12N15/81 0
To view Antheia’s complete patent history, request access »

Antheia Executive Team (9)

Name Title Board Seat Contact Info
Christina Smolke Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Zack McGahey Chief Operating Officer
Heidi Pucel Chief People Officer
Kristy Hawkins Ph.D Co-Founder, Chief Scientific Officer, Scientist and Board Member
Yen-Hsiang Wang Ph.D Head of Strategy, Partnerships & Finance
You’re viewing 5 of 9 executive team members. Get the full list »

Antheia Board Members (5)

Name Representing Role Since
Christina Smolke Ph.D Antheia Co-Founder, Chief Executive Officer, President & Board Member 000 0000
John Nicols Self Chairman 000 0000
Kristy Hawkins Ph.D Antheia Co-Founder, Chief Scientific Officer, Scientist and Board Member 000 0000
Patrick Yang Ph.D Self Board Member 000 0000
Ram Shriram Self Board Member 000 0000
To view Antheia’s complete board members history, request access »

Antheia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Antheia Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hillspire Family Office Minority 000 0000 000000 0
Irregular Expressions Venture Capital Minority 000 0000 000000 0
Viking Global Investors Hedge Fund Minority 000 0000 000000 0
Western Technology Investment Venture Capital Minority 000 0000 000000 0
Codon Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Antheia FAQs

  • When was Antheia founded?

    Antheia was founded in 2013.

  • Who is the founder of Antheia?

    Christina Smolke Ph.D, Kristy Hawkins Ph.D, Isis Trenchard Ph.D, and Catherine Thodey are the founders of Antheia.

  • Who is the CEO of Antheia?

    Christina Smolke Ph.D is the CEO of Antheia.

  • Where is Antheia headquartered?

    Antheia is headquartered in Menlo Park, CA.

  • What is the size of Antheia?

    Antheia has 52 total employees.

  • What industry is Antheia in?

    Antheia’s primary industry is Biotechnology.

  • Is Antheia a private or public company?

    Antheia is a Private company.

  • What is Antheia’s current revenue?

    The current revenue for Antheia is 00000.

  • How much funding has Antheia raised over time?

    Antheia has raised $135M.

  • Who are Antheia’s investors?

    Hillspire, Irregular Expressions, Viking Global Investors, Western Technology Investment, and Codon Capital are 5 of 14 investors who have invested in Antheia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »